Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Diener, Markus K ^a   Fitzmaurice, Christina ^b   Schwarzer, Guido ^c   Seiler, Christoph M ^a   Hüttner, Felix J ^a   Antes, Gerd ^c   Knaebel, Hanns Peter ^d   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d B Braun Melsungen AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BILE LEAKAGE; CANCER SURVIVAL; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LUNG DISEASE; MORBIDITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; REOPERATION; REVIEW; STOMACH EMPTYING; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; VATER PAPILLA CARCINOMA; ADVERSE EFFECTS; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; CONSERVATIVE TREATMENT; META ANALYSIS; MORTALITY; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PROCEDURES; PYLORUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AMPULLA OF VATER; BLOOD LOSS, SURGICAL; COMMON BILE DUCT NEOPLASMS; GASTRIC EMPTYING; HUMANS; OPERATIVE TIME; ORGAN SPARING TREATMENTS; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PYLORUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84994070681     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006053.pub5     Document Type: Review

References (65)

1. Bloechle C, Broering DC, Latuske C. Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to Whipple versus pylorus preserving pancreatoduodenectomy according to Longmire-Traverso for periampullary carcinoma. Deutsche Gesellschaft für Chirurgie 1999;Supplement 1, Forumband:661-4.
2. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. British Journal of Surgery 1999;86(5):603-7.
3. Lin PW, Shan YS, Lin YJ, Hung CJ. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 2005;52(65):1601-4.
4. Paquet K-J. Comparison of Whipple's pancreaticoduodenectomy with the pylorus-preserving pancreaticoduodenectomy - a prospectively controlled, randomized long-term trial [Vergleich der partiellen Duodenopankreatektomie (Whipple-Operation) mit der pyloruserhaltenden Zephaloduodenopankreatektomie - eine prospektive kontrollierte, randomisierte Langzeitstudie]. Chirurgische Gastroenterologie 1998;14:54-8.
5. Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, et al.Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection - long term results. British Journal of Surgery 2005;92(5):547-56.
6. Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW, et al.Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Annals of Surgery 2004;240(5):738-45.
7. Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg 1999;70:1454-9.
8. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Annals of Surgery 1993;217(4):356-68.
9. Bassi C, Falconi M, Lobardi D, Briani G, Vesentini S, Camboni MG, et al.Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. Digestion 1994;55(Suppl 1):41-7.
10. Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treatment Reviews 2005;31(4):328-31.
11. Brennan MF, Pisters PW, Posner M, Quesada O, Shike M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Annals of Surgery 1994;220(4):436-41; discussion 441-4.
12. Buchler M, Friess H. Prevention of postoperative complications following pancreatic surgery. Digestion 1993;54(Suppl 1):41-6.
13. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL. Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer. European Journal of Surgery 1996;162(6):477-81.
14. Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al.A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138(4):618-28; discussion 628-30.
15. Friess H, Berberat P, Schilling M, Kunz J, Korc M, Buchler MW. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. Journal of Molecular Medicine 1996;74(1):35-42.
16. Johnstone PA, Sindelar WF. Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas 1993;8(5):535-9.
17. Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA, Coleman J, et al.Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. Journal of Gastrointestinal Surgery 2003;7(1):1-9; discussion 9-11.
18. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al.Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Annals of Surgery 1998;228(4):508-17.
19. Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. Journal of Gastrointestinal Surgery 2000;4(5):443-52. [PUBMED: 11077317].
20. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World Journal of Surgery 2003;27(6):709-14.
21. van Berge Henegouwen MI, Moojen TM, van Gulik TM, Rauws EA, Obertop H, Gouma DJ. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. British Journal of Surgery 1998;85(7):922-6.
22. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. British Journal of Surgery 2004;91(5):586-94.
23. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, et al.Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Annals of Surgery 1999;229(5):613-22; discussion 622-4.
24. Bassi C, Falconi M, Salvia R, Mascetta G, Molinari E, Pederzoli P. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Digestive Surgery 2001;18(6):453-7.
25. Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H, et al.Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Digestive Surgery 2005;22(5):353-63.
26. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al.Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138(1):8-13.
27. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Archives of Surgery 2003;138(12):1310-4.
28. Butturini G, Marcucci S, Molinari E, Mascetta G, Landoni L, Crippa S, et al.Complications after pancreaticoduodenectomy: the problem of current definitions. Journal of Hepato-Biliary-Pancreatic Surgery 2006;13(3):207-11.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
30. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology & Community Health 1998;52(6):377-84.
31. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al.Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94(10):2766-92.
32. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
33. Egger M, Smith GD. Meta-analysis. Potentials and promise. BMJ 1997;315(7119):1371-4.
34. Fitzsimmons D, Johnson CD. Quality of life after treatment of pancreatic cancer. Langenbecks Archives of Surgery 1998;383(2):145-51.
35. Gouma DJ, Nieveen van Dijkum EJ, van Geenen RC, van Gulik TM, Obertop H. Are there indications for palliative resection in pancreatic cancer?. World Journal of Surgery 1999;23(9):954-9.
36. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al.Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Annals of Surgery 2000;232(6):786-95.
37. Brozek J, Oxman A, Schünemann H. GRADEpro. 3.2 for Windows. GRADE Working Group, 2008.
38. Appendix 5b. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. In: Higgins JPT, Green S, editors. Cochrane Handbook of Systematic Reviews of Interventions 4.2.5. The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley and Sons, Ltd.
39. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
40. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A. Cancer statistics, 2005. CA: A Cancer Journal for Clinicians 2005;55(1):10-30.
41. Kausch W. Carcinoma of the duodenal papilla and its radical excision [Das Carcinom der Papilla duodeni und seine radikale Entfernung]. Beitrage zur Klinischen Chirurgie 1912;78:439-86.
42. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
43. Koslowsky TC, Wilke J, Voiss W, Michaelis S, Balta D, Siedek M. Surgical palliation of pancreatic carcinoma. Results of a 7 year period. Chirurg 2001;72(6):704-9.
44. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, et al.Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?. Annals of Surgery 1996;223(6):718-25.
45. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA: A Cancer Journal for Clinicians 2000;50(4):241-68.
46. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
47. Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F, et al.Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery 1997;122(3):553-66.
48. Mulrow CD. Rationale for systematic reviews. BMJ 1994;309(6954):597-9.
49. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al.Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Annals of Surgery 2001;234(6):758-68.
50. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
51. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World Journal of Surgery 2003;27(3):324-9.
52. Roder JD, Stein HJ, Huttl W, Siewert JR. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. British Journal of Surgery 1992;79(2):152-5.
53. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
54. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. British Journal of Surgery 1996;83(5):625-31.
55. Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy: a follow-up evaluation. Annals of Surgery 1980;192(3):306-10.
56. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Annals of Surgery 1990;211(4):447-58.
57. Trede M, Carter DC. Surgery of the Pancreas. New York: Churchill Livingstone, 1993.
58. Watson K. Carcinoma of the ampulla of Vater. Successful radical resection. British Journal of Surgery 1944;31:368-73.
59. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al.Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142(1):20-5.
60. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Annals of Surgery 1935;102:763-79.
61. Williamson RC, Bliouras N, Cooper MJ, Davies ER. Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy. Surgery 1993;114(1):82-6.
62. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al.Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Annals of Surgery 1995;221(6):721-31.
63. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al.Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Annals of Surgery 1997;226(3):248-57.
64. Diener MK, Knaebel HP, Heukaufer C, Antes G, Buchler MW, Seiler CM. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Annals of Surgery 2007;245(2):187-200.
65. Diener MK, Heukaeufer C, Schwarzer G, Seiler CM, Antes G, Knaebel H-P, et al.Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006053.pub2].